Black Rock Inc. Neuro Bo Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.36 - $123.84 $7,652 - $2.63 Million	-21,257 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.4 - $0.9 $9,132 - $20,547	-22,830 Reduced 51.78%	21,257 $10,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.54 $797 - $1,704	-1,107 Reduced 2.45%	44,087 $41,000
Q4 2021 Feb 10, 2022	BUY	$1.22 - $2.5 $750 - $1,537	615 Added 1.38%	45,194 $55,000
Q3 2021 Nov 09, 2021	SELL	$2.73 - $4.52 $15,530 - $25,714	-5,689 Reduced 11.32%	44,579 $166,000
Q2 2021 Aug 11, 2021	BUY	$2.74 - $4.63 $137,734 - $232,740	50,268 New	50,268 $167,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.